Showing results (171-180 of 259) with videos related to

Sort By:
Pageof 26
International Journal of Urology : Official Journal of the Japanese Urological Association|May 10, 2026
Comparative Efficacy of First-Line Immune Checkpoint Inhibitor-Based Combination Therapies in Patients With Sarcomatoid Renal Cell Carcinoma: A Japanese Multicenter Cohort StudyKeita Tamura, Yuto Matsushita, Hiromitsu Watanabe, et al.
The Journal of Urology|August 30, 2014
Novel bladder preservation therapy with Osaka Medical College regimenHaruhito Azuma, Teruo Inamoto, Kiyoshi Takahara, et al.
World Journal of Urology|November 26, 2013
Single session of high-intensity focused ultrasound for localized prostate cancer: treatment outcomes and potential effect as a primary therapyKazumasa Komura, Teruo Inamoto, Tomoaki Takai, et al.
Oncology|April 7, 2026
Hypoxia-Induced microRNAs confer survival advantage in bladder cancer by fine-tuning oncogenic PathwaysTakaya Ohno, Yuki Nakajima, Yuki Yoshikawa, et al.
International Journal of Oncology|August 13, 2013
A great option for elderly patients with locally invasive bladder cancer, BOAI-CDDP-radiation (OMC regimen)Haruhito Azuma, Teruo Inamoto, Kiyoshi Takahara, et al.
International Journal of Clinical Oncology|June 11, 2026
Differential impact of host-related factors on survival outcomes between IO+IO and IO+TKI in metastatic renal cell carcinoma: a multicenter retrospective studyKoichi Sugimoto, Shingo Toyoda, Lan Inoki, et al.
Photodiagnosis and Photodynamic Therapy|January 12, 2016
The clinical trial on the safety and effectiveness of the photodynamic diagnosis of non-muscle-invasive bladder cancer using fluorescent light-guided cystoscopy after oral administration of 5-aminolevulinic acid (5-ALA)Keiji Inoue, Hideyasu Matsuyama, Kiyohide Fujimoto, et al.
Scientific Reports|January 13, 2026
Comparative efficacy of immune checkpoint inhibitor combination therapies by metastatic site in metastatic renal cell carcinomaShingo Toyoda, Lan Inoki, Mamoru Hashimoto, et al.
Journal of the National Cancer Institute|December 8, 2005
Effect of Smad7 expression on metastasis of mouse mammary carcinoma JygMC(A) cellsHaruhito Azuma, Shogo Ehata, Hideyo Miyazaki, et al.
Translational Andrology and Urology|September 15, 2025
Upper urinary tract urothelial carcinoma patients show better overall response rate than bladder cancer patients during enfortumab vedotin treatment following pembrolizumabMamoru Hashimoto, Ken Fukiage, Kosei Taniguchi, et al.
Pageof 26